Quick Answer
Cadrenal Therapeutics, Inc. reported Total Assets of $4.33 million for fiscal year 2025.
Cadrenal Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $4.33M | -57.3% |
| 2024 | $10.12M | +18.8% |
| 2023 | $8.52M | +994.8% |
| 2022 | $778.2K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $4.09M | -12.6% | -31.6% |
| June 30, 2025 | $5.98M | +9.6% | -24.8% |
| March 31, 2025 | $7.95M | +12.8% | -21.4% |
| December 31, 2024 | $10.12M | +18.8% | +116.3% |
| September 30, 2024 | $4.68M | -49.7% | -14.3% |
| June 30, 2024 | $5.46M | +53.3% | -22.6% |
| March 31, 2024 | $7.05M | +57.3% | -17.3% |
| December 31, 2023 | $8.52M | +994.8% | -8.5% |
- Cadrenal Therapeutics, Inc. showed a decrease of -57.3% in Total Assets compared to the prior fiscal year.
- Over the 2022–2025 period, Cadrenal Therapeutics, Inc.’s total assets has grown by 456.0% (from $778.2 thousand to $4.33 million).
- The most recent figure is from Cadrenal Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: